FEATURED/ARCHIVES (29/04/24)
The Effect of Drug Use, Body Mass Index and Blood Pressure on Oxidative Stress Levels in Children and Adolescents with Attention Deficit and Hyperactivity Disorder · February 2023
Articles
Clinical Psychopharmacology and Neuroscience
Association between Antipsychotic Medication and Clinically Relevant Weight Change: Meta-Analysis · January 2023
Articles
BJPsych Open
An Open-Label Trial on the Efficacy and Tolerability of Naltrexone/Bupropion SR for Treating Altered Eating Behaviours and Weight Loss in Binge Eating Disorder · April 2020
Abstracts
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children · March 2021
Articles
Frontiers in Psychiatry
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials · February 2022
Articles
Schizophrenia Bulletin
The Association between BDNF Levels and Risperidone-Induced Weight Gain Is Dependent on the BDNF Val66Met Polymorphism in Antipsychotic-Naive First Episode Schizophrenia Patients: A 12-Week Prospective Study · September 2021
Articles
Translational Psychiatry
Long-Term Psychoeducation in Limiting Body Mass Gain in Patients Treated with Atypical Antipsychotics · April 2021
Articles
Psychiatria Polska
Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis · July 2021
Articles
Frontiers in Endocrinology
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/Bupropion as Add-On to Antidepressant Therapy in Patients with Obesity or Overweight · April 2021
Articles
Journal of Affective Disorders
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: Two Randomized Clinical Trials · May 2022
Articles
Schizophrenia Bulletin
Efficacy of Multidisciplinary Interventions in Preventing Metabolic Syndrome and Improving Body Composition in Prostate Cancer Patients Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis · September 2023
Articles
Clinical Nutrition ESPEN
Effect of Bifidobacterium on Olanzapine-Induced Body Weight and Appetite Changes in Patients with Psychosis · May 2021
Abstracts
Psychopharmacology
Antioxidant Enzymes and Weight Gain in Drug-Naive First-Episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
Comparison of Olanzapine-Induced Weight Gain and Metabolism Abnormalities between Topiramate and Vitamin C in Patients with Schizophrenia: A Preliminary Study · May 2023
Articles
Frontiers in Psychiatry
Metformin in the Management of Antipsychotic-Induced Weight Gain in Adults with Psychosis: Development of the First Evidence-Based Guideline Using GRADE Methodology · September 2021
Articles
Evidence-Based Mental Health
Metabolic Biomarkers of Risperidone-Induced Weight Gain in Drug-Naive Patients with Schizophrenia · April 2023
Articles
Frontiers in Psychiatry
Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-Induced Weight Gain · February 2020
Articles
Clinical Psychopharmacology and Neuroscience
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Psychiatric Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Pharmacovigilance Analysis of Individual Case Safety Reports Submitted to the Eudravigilance Database · January 2024
Articles
International Journal of Clinical Pharmacy
Risperidone-Induced Obesity in Children and Adolescents with Autism Spectrum Disorder: Genetic and Clinical Risk Factors · November 2020
Articles
Frontiers in Pharmacology